Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels

Publisher： Karger

E-ISSN： 1662-680x|8|2|179-184

ISSN： 1662-680x

Source： Case Reports in Neurology, Vol.8, Iss.2, 2016-08, pp. : 179-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD8+CD11ahigh Cells Decreased in Multiple Sclerosis but Not in Neuromyelitis Optica

By  

European Neurology, Vol. 63, Iss. 3, 2010-02 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 4, 2011-03 ,pp. : 231-232

Karger

Access to resources Recommend Favorite

Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis

By Butteriss D J A   Ismail A   Ellison D W   Birchall D  

British Journal of Radiology, Vol. 76, Iss. 909, 2003-09 ,pp. : 662-665

British Institute of Radiology

Access to resources Recommend Favorite

Acute Fulminant Multiple Sclerosis and Plasma Exchange

By  

European Neurology, Vol. 41, Iss. 3, 1999-04 ,pp. : 174-175

Karger

Access to resources Recommend Favorite

Induction of Apoptosis of CD4+ T Cells by Immunomodulatory Therapy of Multiple Sclerosis with Glatiramer Acetate

By  

European Neurology, Vol. 50, Iss. 4, 2003-11 ,pp. : 200-206

Karger

Access to resources Recommend Favorite